Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
11/27/2003 | CA2486133A1 Injection formulation |
11/27/2003 | CA2485989A1 Methods and compositions for the treatment of ischemic reperfusion |
11/27/2003 | CA2485463A1 A direct cellular energy delivery system |
11/27/2003 | CA2485399A1 Co-grinding process for the preparation of a ternary composition |
11/27/2003 | CA2484512A1 Treatment of cataracts and other ophthalmic diseases |
11/27/2003 | CA2483190A1 External preparation for allergic diseases |
11/27/2003 | CA2482746A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
11/27/2003 | CA2471879A1 Pharmaceutical composition containing ghrelin |
11/26/2003 | EP1364718A1 Device and method for producing stationary multi-component liquid capillary streams and micrometric and nanometric sized capsules |
11/26/2003 | EP1364660A1 Drug-releasing system of biodegradable polymer type |
11/26/2003 | EP1364654A1 Eye drops |
11/26/2003 | EP1364650A1 Medicinal composition |
11/26/2003 | EP1364648A1 Cryptotanshinone for preventing and alleviating alzheimer's disease |
11/26/2003 | EP1364646A1 Fenofibrate-containing composition |
11/26/2003 | EP1364644A1 Pharmaceutical formulation with extended release |
11/26/2003 | EP1364643A1 Composition improved in solubility or oral absorbability |
11/26/2003 | EP1364642A1 Composition for delivery of dithranol |
11/26/2003 | EP1363964A1 Polymer comprising water-soluble units and lcst units and aqueous composition containing same |
11/26/2003 | EP1363951A2 Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex |
11/26/2003 | EP1363933A2 Sterol derivatives, liposomes comprising sterol derivatives and method for loading liposomes with active substances |
11/26/2003 | EP1363932A2 Amphoteric sterols and the use thereof |
11/26/2003 | EP1363892A1 Stable pharmaceutical form of an anticancer drug |
11/26/2003 | EP1363877A2 Benzophenones as inhibitors of reverse transcriptase |
11/26/2003 | EP1363730A1 Process for making microcapsules involving phase inversion |
11/26/2003 | EP1363696A1 Geometry retainable devices for body cavities |
11/26/2003 | EP1363673A2 Compositions for reducing side effects in chemotherapeutic treatments |
11/26/2003 | EP1363672A1 Carrier systems comprising vitamin b12 - biodegradable micro particulate conju gates for peroral delivery of drugs, peptides/proteins and vaccines |
11/26/2003 | EP1363671A2 Water-soluble compositions of bioactive lipophilic compounds |
11/26/2003 | EP1363670A1 Polynucleotide formulation for enhanced intracellular transfer |
11/26/2003 | EP1363666A1 Methods for treating disease states comprising administration of low levels of antibodies |
11/26/2003 | EP1363651A1 Herbal compositions useful as chemopreventive and therapeutic agents |
11/26/2003 | EP1363647A1 A method to enhance the immune system and used for the prevention and treatment of infectious diseases |
11/26/2003 | EP1363641A1 Progestin co-micronized with a surfactant, pharmaceutical composition comprising same, methods for making same and uses thereof |
11/26/2003 | EP1363637A1 Pyrimidine compounds and methods for making and using the same |
11/26/2003 | EP1363633A1 A process for the manufacture of pharmaceutical tablets containing paroxetine hydrochloride anhydrate |
11/26/2003 | EP1363626A1 Antifungal remedy formulation for external application |
11/26/2003 | EP1363622A1 Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle |
11/26/2003 | EP1363621A1 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
11/26/2003 | EP1363617A1 Cyanoacrylate compositions for prophylactic or therapeutic treatment of diseases manifesting themselves in and/or damaging cutaneous tissue |
11/26/2003 | EP1363614A2 Use of 2-amino-1(4-hydroxy-2-methanesulphonamidophenyl)ethanol for treating urinary incontinence |
11/26/2003 | EP1363611A1 Retinoid hepatitis therapy |
11/26/2003 | EP1363608A1 Treatment of sleep disturbances |
11/26/2003 | EP1363607A2 Pharmaceutical formulation |
11/26/2003 | EP1363604A2 Pharmaceutical formulation |
11/26/2003 | EP1363603A1 Method for making water soluble a poorly water-soluble antiseptic |
11/26/2003 | EP1363602A1 Local anesthetic, and method of use |
11/26/2003 | EP1363601A2 Amphoteric liposomes and the use thereof |
11/26/2003 | EP1363600A1 Liquid formulations for the prevention and treatment of mucosal diseases and disorders |
11/26/2003 | EP1363585A2 Cosmetic or pharmaceutical agent |
11/26/2003 | EP1363556A2 Novel in-situ forming controlled release microcarrier delivery system |
11/26/2003 | EP1363550A2 A compound and method of treatment for fungal pathologies of the oral cavity |
11/26/2003 | EP1363538A2 Enhanced ultrasound detection with temperature dependent contrast agents |
11/26/2003 | EP1363508A1 Emulsions and aqueous dispersions of phytosterols |
11/26/2003 | EP1227877B1 Polydisperse double emulsion, corresponding monodisperse double emulsion and method for preparing the monodisperse emulsion |
11/26/2003 | EP1176982B1 Prucalopride oral solution |
11/26/2003 | EP1140034B1 Controlled release formulation of divalproex sodium |
11/26/2003 | EP1124603B1 Vaporizing device for administering sterile medication |
11/26/2003 | EP1124541B1 Application of water-soluble or water-dispersible graft polymerizates which contain poly-ether and which are used as a coating agent, a binding agent and/or as a film-forming auxiliary agent in pharmaceutical forms of administration |
11/26/2003 | EP1086706B1 Stabilized compositions containing nootropic drugs |
11/26/2003 | EP1083902B1 Novel galenic formulations of meloxicam for oral administration |
11/26/2003 | EP1067934B1 Oral liquid solution comprising the antidepressant mirtazapine |
11/26/2003 | EP1037614B1 A double capsule for the administration of active principles in multiple therapies |
11/26/2003 | EP0948322B1 Mucosal administration of substances to mammals |
11/26/2003 | EP0818195B1 Gelatin capsule with adjusted water activity |
11/26/2003 | CN2587415Y Anti-tumor pill |
11/26/2003 | CN1458936A HIV peptides from Tat, Rev and Nef conserved regions and their application as E.G. vaccine components |
11/26/2003 | CN1458935A Integrain binding motif containing peptides and methods of treating skeletal diseases |
11/26/2003 | CN1458862A Continuous production of pharmaceutical granulation |
11/26/2003 | CN1458850A Peritoneal dialysates and its preparing method |
11/26/2003 | CN1458847A Preparation for enhancement of action of anti-infective agent and method |
11/26/2003 | CN1458845A Pharmaceutical composition comprising condensed indole compound |
11/26/2003 | CN1458840A Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
11/26/2003 | CN1457886A Process for preparing poly lactic acid super microball carrying medicine |
11/26/2003 | CN1457883A Alpha type recombined human interferon suppository and producing process |
11/26/2003 | CN1457882A Recombined human interleukin-2 and its derivative injection and preparing method |
11/26/2003 | CN1457880A Polyresistin dripping pill and its preparing method for immunodeficiency |
11/26/2003 | CN1457877A Aikang soft capsule fortreating AIDS and preparing method |
11/26/2003 | CN1457873A Process for preparing kidney-tonifying wolfberry fruit capsule |
11/26/2003 | CN1457872A Quick-acting paste for burn and scald without leaving scar and its bandaging therapeutic method |
11/26/2003 | CN1457867A Medicine powder for clearing away toxic matter and promoting granulation |
11/26/2003 | CN1457864A Pill for treating pestilence, high fever and headache |
11/26/2003 | CN1457863A Pill for treating apoplexy and hemiparalysis |
11/26/2003 | CN1457862A Paste for treating cardio-cerebral vascular diseases, hepatitis and ruducing blood fat and blood pressure |
11/26/2003 | CN1457861A Analgesic paste for hyperosteogeny, necrosis and cervical vertebrae disease |
11/26/2003 | CN1457857A Prepared licorice granular powder |
11/26/2003 | CN1457854A Health pill for liver |
11/26/2003 | CN1457848A Black-bone chicken white phoenix preparation medicine and its preparing method |
11/26/2003 | CN1457847A Composition of full scorpion powder and centipede powder and its preparing method |
11/26/2003 | CN1457835A Draqon's blood dripping pill for removing blood stasis and killing pain, arresting bleeding and promoting granulation and its preparing method |
11/26/2003 | CN1457824A Chinese medicinal pill for reinforcing kidney and strengthening yang, warming and recuperating Qi and blood, and improving crganism immunity |
11/26/2003 | CN1457823A Amomum fruit oil soft capsule |
11/26/2003 | CN1457822A Medicine for preventing and treating bone fracture and osteoporosis |
11/26/2003 | CN1457812A Chinese medicinal tincture for curing burn and scald and its preparing method |
11/26/2003 | CN1457804A Adhesive plaster for curing lymph disease, red wound and lump furuncle |
11/26/2003 | CN1457802A Snake powder and leech powder composition and preparing method |
11/26/2003 | CN1457800A Formula of anti-senility tablet and preparing method |
11/26/2003 | CN1457796A Ribavirin inhalation powder atomizing agent and its preparing process and anti-virus infection use |
11/26/2003 | CN1457795A Pueraria root flavone self-microemulsified soft capsule and its preparing method |
11/26/2003 | CN1457785A Doxazosin mesilate slow releasing preparation |
11/26/2003 | CN1457784A Method for producing xinnaoning injectin containing chuanxiong rhizome and red sage root extract |